Identification of ML251, a Potent Inhibitor ofT. brucei and T. cruziPhosphofructokinase

ACS Medicinal Chemistry Letters
2014.0

Abstract

Human African Trypanosomiasis (HAT) is a severe, often fatal disease caused by the parasitic protist Trypanosoma brucei. The glycolytic pathway has been identified as the sole mechanism for ATP generation in the infective stage of these organisms, and several glycolytic enzymes, phosphofructokinase (PFK) in particular, have shown promise as potential drug targets. Herein, we describe the discovery of ML251, a novel nanomolar inhibitor of T. brucei PFK, and the structure-activity relationships within the series.

Knowledge Graph

Similar Paper

Identification of ML251, a Potent Inhibitor ofT. brucei and T. cruziPhosphofructokinase
ACS Medicinal Chemistry Letters 2014.0
Pharmacological Validation of Trypanosoma brucei Phosphodiesterases B1 and B2 as Druggable Targets for African Sleeping Sickness
Journal of Medicinal Chemistry 2011.0
Catechol Pyrazolinones as Trypanocidals: Fragment-Based Design, Synthesis, and Pharmacological Evaluation of Nanomolar Inhibitors of Trypanosomal Phosphodiesterase B1
Journal of Medicinal Chemistry 2012.0
Inhibition ofTrypanosomacruziHexokinase by Bisphosphonates
Journal of Medicinal Chemistry 2006.0
Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): Their effects on three selected glycolytic enzymes of Trypanosoma brucei
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
Journal of Medicinal Chemistry 2012.0
Identification of novel inhibitors of UDP-Glc 4′-epimerase, a validated drug target for african sleeping sickness
Bioorganic & Medicinal Chemistry Letters 2006.0
Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): Their effects on three selected glycolytic enzymes of Trypanosoma brucei
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor
Bioorganic & Medicinal Chemistry 2016.0
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity
Journal of Medicinal Chemistry 2018.0